{"id":281800,"date":"2022-12-05T05:30:00","date_gmt":"2022-12-05T13:30:00","guid":{"rendered":"https:\/\/calmatters.org\/?p=281800"},"modified":"2023-05-02T13:59:05","modified_gmt":"2023-05-02T20:59:05","slug":"covid-antivirals","status":"publish","type":"post","link":"https:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/","title":{"rendered":"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them"},"content":{"rendered":"<div class=\"wp-block-group has-light-gray-background-color has-background calmatters-summary\">\n\t\t\t<div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n\t\t\t\t\n\t\t\t\t<p class=\"has-small-font-size calmatters-summary-heading\"><strong>\uc694\uc57d\ud574\uc11c<\/strong><\/p>\n\t\t\t\t\n\n\t\t\t\t\n\t\t\t\t<p class=\"calmatters-summary-content\">Health officials say a key difference between this upcoming winter and the last two is the wider availability of COVID antivirals like Paxlovid. But many infected people aren\u2019t aware of their availability or have difficulty accessing them. <\/p>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\n\t\t\n<p><em>\uc774 \uae30\uc0ac\ub294 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4. <\/em><a href=\"https:\/\/calmatters.org\/calmatters-en-espanol\/2022\/12\/el-suministro-de-antivirales-para-el-covid-ha-aumentado-pero-muchos-pacientes-no-los-estan-usando\/\"><em>\uc2a4\ud398\uc778\uc5b4<\/em><\/a><em>.<\/em><\/p>\n\n\n\n<p>As California gears up for <a href=\"https:\/\/calmatters.org\/newsletters\/whatmatters\/2022\/11\/california-flu-covid-rsv\/\">a winter of respiratory illnesses<\/a>, health officials and providers often reference one encouraging factor \u2014 the greater availability of COVID-19 treatments and antivirals like Paxlovid. But many patients aren\u2019t using them.&nbsp;&nbsp;<\/p>\n\n\n\n<p>\u201cWe have a concerning low rate of outpatient COVID-19 treatments, especially for vulnerable populations,\u201d Dr. Rohan Radhakrishna, chief equity officer at the California Department of Public Health, told doctors <a href=\"https:\/\/www.youtube.com\/watch?v=XcKZLaIyR8Y&amp;t=3s\">in an online event<\/a> in November. \u201cWe want to remind the provider community that therapeutics are in ample supply and that most adults have qualifying conditions.\u201d&nbsp;<\/p>\n\n\n\n<p>Some county health officials agreed that more people should be taking advantage of these treatments. Patients may not be using them for a number of reasons, they said, including lack of awareness and confusion over who qualifies for a prescription. Add to that some people\u2019s concerns over \u201cPaxlovid rebound,\u201d when people test positive again soon after having tested negative. There is also a need for easier and quicker access, experts say. Anecdotally, people have found some providers more strictly limit which patients get prescriptions.<\/p>\n\n\n\n<p>The \u201cmisperception of drug scarcity\u201d has resulted in some providers denying treatment to eligible people, the state\u2019s public health department noted <a href=\"http:\/\/publichealth.lacounty.gov\/eprd\/lahan\/alerts\/CDPHAlert_Remindertoprescribe_11.29.22.pdf\">in a health notice<\/a> sent to providers last week.&nbsp;&nbsp;<\/p>\n\n\n\n<p>\u201cI can share from personal experience from family members to my colleagues within the Department of Public Health who got COVID this summer \u2014&nbsp;although they qualified for Paxlovid, it was really hard to get,\u201d Radhakrishna said. People shouldn\u2019t have to pull special strings to get these treatments, he said.&nbsp;<\/p>\n\n\n\n<p>The department\u2019s message comes as <a href=\"https:\/\/calmatters.org\/health\/coronavirus\/2020\/04\/california-coronavirus-covid-patient-hospitalization-data-icu\/\">hospitalizations have more than doubled since Nov. 1<\/a>, and the positivity rate is once again in the double digits \u2014 <a href=\"https:\/\/covid19.ca.gov\/state-dashboard\/\">10.8% as of the latest update<\/a> on Thursday.<\/p>\n\n\n\n<div id=\"pymTarget\"><\/div>\n<script src=\"https:\/\/pym.nprapps.org\/pym.v1.min.js\"><\/script>\n<script type=\"text\/javascript\">\n    new pym.Parent('pymTarget', 'https:\/\/calmatters-covid-19-hospitalizations-dashboard.netlify.app\/area-chart-conf.html', {});\n<\/script>\n\n\n\n<p>Paxlovid, the most commonly prescribed treatment, is an oral medication that can help reduce the severity and length of symptoms and decrease the chances of hospitalization. Pfizer, which makes the drug, reported in <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2118542\">published clinical trials<\/a> that it reduces the risk of severe COVID by 89%. Staying out of the emergency room is especially important when hospitals in parts of the state are being strained by other respiratory illnesses, health officials say. A second oral antiviral, Lagevrio, made by Merck, is also available with a prescription.&nbsp;<\/p>\n\n\n\n<p>One year ago, the U.S. Food and Drug Administration approved the first antivirals for emergency use. The initial rollout was hindered by low supply and <a href=\"https:\/\/www.nytimes.com\/2022\/01\/06\/business\/covid-paxlovid-antibodies-omicron.html\">treatments were rationed<\/a> during last winter\u2019s omicron surge. Gradually, availability has increased and the federal government and states have worked to increase the number of places where patients can get treatment.<\/p>\n\n\n\n<p>As of Nov. 27, providers had administered 72% of all Paxlovid units allocated to California and 21% of Lagevrio, <a href=\"https:\/\/aspr.hhs.gov\/COVID-19\/Therapeutics\/Orders\/Documents\/state-data.pdf\">according to federal data<\/a>. Nationally, those numbers were 66% for Paxlovid and 31% for Lagevrio.<\/p>\n\n\n\n<p>The California Department of Public Health said in an email response that it did not expect the supply of antivirals to be an issue in case of another uptick in infections this winter.&nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-pullquote has-spirited-yellow-background-color has-background\"><blockquote><p>\u201cWe want to remind the provider community that therapeutics are in ample supply and that most adults have qualifying conditions.\u201d<\/p><cite>Dr. Rohan Radhakrishna, chief equity officer at the California Department of Public Health<\/cite><\/blockquote><\/figure>\n\n\n\n<p>\uad6d\uac00\uc758 <a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7125e1.htm\">analyses of antiviral prescriptions<\/a> have shown that despite the growing availability of these medications, uptake is lower in poorer zip codes \u2014 a disparity that was also seen with vaccination and testing. One possible factor: There tends to be <a href=\"https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/how-equitable-is-access-to-covid-19-treatments\/\">fewer facilities with treatments available<\/a> in rural and high-poverty counties, according to a national Kaiser Family Foundation analysis from this summer.&nbsp;<\/p>\n\n\n\n<p>Dr. Rais Vohra, Fresno County\u2019s public health officer, said one of the easiest ways to increase the use of antivirals is to promote them at the time of testing.<\/p>\n\n\n\n<p>\u201cAt the time that you swab someone, we should say \u2018I\u2019m going to swab you. If it comes back positive, I want you to call this phone number and they can set you up with oral medications.\u2019 That really should be the new model for COVID care for the outpatient setting,\u201d Vohra said.&nbsp;<\/p>\n\n\n\n<p>But that\u2019s not the case in most places. And as more people test at home, the onus is on patients to learn on their own what\u2019s available.<\/p>\n\n\n\n<p>\u201cA large part of it is just plain ignorance that they (treatments) are even out there,\u201d Vohra said. \u201cI think a lot of us are kind of anchored in the early days of the pandemic. However, now that these therapies have come along, we really need to change the mental model.\u201d<\/p>\n\n\n\n<figure class=\"wp-block-pullquote has-spirited-yellow-background-color has-background\"><blockquote><p>\u201cA large part of it is just plain ignorance that they (treatments) are even out there.\u201d<\/p><cite>Dr. Rais Vohra, Fresno County\u2019s public health officer<\/cite><\/blockquote><\/figure>\n\n\n\n<p>Local health officials say there also needs to be greater clarity about who qualifies. Some people may be aware that antivirals are available, but they may not realize they themselves are eligible, so they don\u2019t seek out treatment, said Dr. Jennifer Chevinsky, Riverside County\u2019s public health officer.&nbsp;<\/p>\n\n\n\n<p>For example, all people over age 50 should be screened for Paxlovid, Chevinsky said. And the state has asked local health departments and providers to look more broadly at the type of health conditions that can put people at high risk, she said.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Most adults actually have a qualifying condition, according to the state\u2019s health department. These include a number of chronic diseases, hypertension, obesity, depression, smoking and physical inactivity.&nbsp;<\/p>\n\n\n\n<p>One piece of advice from Chevinsky, especially for people who use other medications: They should contact their provider and make a plan even before they catch COVID. That way if people do become infected, they will already know whether they qualify for Paxlovid and how they can obtain it.&nbsp;<\/p>\n\n\n\n<p>Experts say that while cases of Paxlovid rebound have received a lot of attention, that shouldn\u2019t discourage people from taking it.&nbsp;<\/p>\n\n\n\n<p>\u201cPeople still have concerns about rebound and we want to remind people that the rate of rebound is low, less than 10%,\u201d Radhakrishna said. \u201cAnd rebound can occur anyway, <a href=\"https:\/\/www.nytimes.com\/2022\/10\/27\/well\/live\/covid-symptoms-rebound-paxlovid.html\">even without Paxlovid<\/a> treatment.\u201d While research is ongoing, experts estimate <a href=\"https:\/\/www.scientificamerican.com\/article\/what-is-paxlovid-rebound-and-how-common-is-it\/\">the rebound rate<\/a> is somewhere in the 2%-to-10% range.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-how-to-access-antivirals\">How to access antivirals<\/h3>\n\n\n\n<p>The time frame to get a prescription also is tight \u2014 people need to start treatment within five to seven days from the onset of symptoms. Primary care providers may be the most convenient option because they already have a patient\u2019s medical history on hand. For people who cannot reach their doctor within the five-day window or don\u2019t have one, however, health officials recommend several other routes, including one-stop sites where people can both get tested and receive medication (also known as \u201cTest to Treat\u201d sites), and a recently launched statewide telehealth service.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Over the summer, the FDA changed its regulations to allow pharmacists to prescribe COVID pills. At large retail pharmacies, patients can seek a screening online and if deemed eligible, get their prescription delivered or picked up by a family member. While antivirals are free, at least one chain pharmacy, CVS, <a href=\"https:\/\/www.cvs.com\/content\/covid-antiviral\">charges $60 for a consultation<\/a>, according to its website.&nbsp;&nbsp;<\/p>\n\n\n\n<p>People can also try the federal \u201c<a href=\"https:\/\/covid-19-test-to-treat-locator-dhhs.hub.arcgis.com\">Test to Treat\u201d locator tool<\/a>, which launched this past spring. This tool directs people to clinics, pharmacies and OptumServe sites. But there are still large swaths of the state, such as rural Northern California, that have few of these sites. For example, the closest \u201cTest to Treat\u201d location for someone living in Chico is in Red Bluff, about a 45 minute drive away, according to the map tool. There are, however, several local pharmacies there that can fill a prescription.&nbsp;<\/p>\n\n\n\n<p>To bridge access gaps, the state also contracted with a telehealth service available to people statewide where they can schedule appointments. <a href=\"https:\/\/sesamecare.com\/covid?sortBy=price\">Virtual visits via Sesame Care<\/a> are free to the patient and paid for by the state. According to the site, the service is available to people who are uninsured or having trouble seeing their primary care provider.<\/p>\n\n\n\n<p>\u201cThe state is trying a lot of different models of \u201cTest to Treat\u201d and some of them are more successful than others,\u201d Vohra said. \u201cThis Sesame platform is great because if you test positive, you can pick up the phone and talk to a prescriber over the phone. Not a lot of people are aware of it.\u201d<\/p>\n\n\n\t<div\n\t\tclass=\"wp-block-newspack-blocks-homepage-articles  wpnbha show-image image-alignbehind ts-4 is-3 is-landscape\"\n\t\tstyle=\"\"\n\t\t>\n\t\t<div data-posts data-current-post-id=\"281800\">\n\t\t\t\t\t\t\t<h2 class=\"article-section-title\">\n\t\t\t\t\t<span>more on covid-19<\/span>\n\t\t\t\t<\/h2>\n\t\t\t\t\t\t\n\t<article data-post-id=\"234158\"\n\t\tclass=\"tag-covid-19 tag-health-care category-coronavirus category-health type-post post-has-image\"\n\t\t\t\tstyle=\"min-height: 0vh; padding-top: 0vh;\"\n\t\t\t\t>\n\t\t\t\t\t\t\t<figure class=\"post-thumbnail\">\n\t\t\t\t\t\t\t\t<a href=\"https:\/\/calmatters.org\/_ko\/health\/coronavirus\/2022\/03\/long-covid-inequities-california\/\" rel=\"bookmark\" tabindex=\"-1\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"900\" src=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/031522_Long_Covid_Vasquez_CM_7339.jpg?resize=1200%2C900&amp;ssl=1\" class=\"attachment-newspack-article-block-landscape-large size-newspack-article-block-landscape-large wp-post-image\" alt=\"\u2018An enormous disabling event\u2019: Long COVID could have inequitable impact on Californians\" data-hero-candidate=\"1\" srcset=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/031522_Long_Covid_Vasquez_CM_7339.jpg?resize=1200%2C900&amp;ssl=1 1200w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/031522_Long_Covid_Vasquez_CM_7339.jpg?resize=800%2C600&amp;ssl=1 800w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/031522_Long_Covid_Vasquez_CM_7339.jpg?resize=400%2C300&amp;ssl=1 400w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/031522_Long_Covid_Vasquez_CM_7339.jpg?resize=200%2C150&amp;ssl=1 200w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/031522_Long_Covid_Vasquez_CM_7339.jpg?resize=1200%2C900&amp;ssl=1&amp;w=370 370w\" sizes=\"auto, (max-width: 34.9rem) calc(100vw - 2rem), (max-width: 53rem) calc(8 * (100vw \/ 12)), (min-width: 53rem) calc(6 * (100vw \/ 12)), 100vw\" \/>\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/figure><!-- .featured-image -->\n\t\t\n\t\t<div class=\"entry-wrapper\">\n\t\t\t\t\t\t<h3 class=\"entry-title\"><a href=\"https:\/\/calmatters.org\/_ko\/health\/coronavirus\/2022\/03\/long-covid-inequities-california\/\" rel=\"bookmark\">\u2018An enormous disabling event\u2019: Long COVID could have inequitable impact on Californians<\/a><\/h3>\t\t\t\t\t\t<p>Latino, Black and low-income people with inadequate health care could suffer the most. California doesn&#8217;t have many long COVID specialists, and disadvantaged communities are underserved.<\/p>\n\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t\t<a href=\"https:\/\/calmatters.org\/_ko\/author\/anaibarra\/\"><img data-recalc-dims=\"1\" alt='\uc544\ubc14\ud0c0 \uc0ac\uc9c4' src=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra.jpg?resize=48%2C48&#038;ssl=1\" srcset='https:\/\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra-96x96.jpg 2x' class='avatar avatar-48 photo' height=\"48\" width=\"48\" \/><\/a>\t\t\t\t\t\t<span class=\"byline\" data-no-translation=\"\">\n\t\t\t\t\t\t\t<span class=\"author-prefix\">by<\/span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"https:\/\/calmatters.org\/_ko\/author\/anaibarra\/\">Ana B. Ibarra<\/a><\/span>\t\t\t\t\t\t<\/span><!-- .author-name -->\n\t\t\t\t\t\t<time class=\"entry-date published updated\" datetime=\"2022-03-24T05:28:00-07:00\" data-no-translation=\"\">3\uc6d4 24, 2022<\/time>\t\t\t\t<\/div><!-- .entry-meta -->\n\t\t\t\t\t\t\t\t<\/div><!-- .entry-wrapper -->\n\t<\/article>\n\n\t\t\n\t<article data-post-id=\"231130\"\n\t\tclass=\"tag-bay-area tag-centers-for-disease-control-and-prevention tag-coronavirus tag-covid-19 category-coronavirus type-post post-has-image\"\n\t\t\t\tstyle=\"min-height: 0vh; padding-top: 0vh;\"\n\t\t\t\t>\n\t\t\t\t\t\t\t<figure class=\"post-thumbnail\">\n\t\t\t\t\t\t\t\t<a href=\"https:\/\/calmatters.org\/_ko\/health\/coronavirus\/2022\/03\/california-covid-risks-cdc\/\" rel=\"bookmark\" tabindex=\"-1\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"900\" src=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/012922-LA-COVID-Masks-REUTERS-CM-01.jpg?resize=1200%2C900&amp;ssl=1\" class=\"attachment-newspack-article-block-landscape-large size-newspack-article-block-landscape-large wp-post-image\" alt=\"Old data? CDC apparently misjudged California&#8217;s COVID risks\" data-hero-candidate=\"1\" srcset=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/012922-LA-COVID-Masks-REUTERS-CM-01.jpg?resize=1200%2C900&amp;ssl=1 1200w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/012922-LA-COVID-Masks-REUTERS-CM-01.jpg?resize=800%2C600&amp;ssl=1 800w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/012922-LA-COVID-Masks-REUTERS-CM-01.jpg?resize=400%2C300&amp;ssl=1 400w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/012922-LA-COVID-Masks-REUTERS-CM-01.jpg?resize=200%2C150&amp;ssl=1 200w, https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/03\/012922-LA-COVID-Masks-REUTERS-CM-01.jpg?resize=1200%2C900&amp;ssl=1&amp;w=370 370w\" sizes=\"auto, (max-width: 34.9rem) calc(100vw - 2rem), (max-width: 53rem) calc(8 * (100vw \/ 12)), (min-width: 53rem) calc(6 * (100vw \/ 12)), 100vw\" \/>\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\n\t\t\t\t\t\t\t<\/figure><!-- .featured-image -->\n\t\t\n\t\t<div class=\"entry-wrapper\">\n\t\t\t\t\t\t<h3 class=\"entry-title\"><a href=\"https:\/\/calmatters.org\/_ko\/health\/coronavirus\/2022\/03\/california-covid-risks-cdc\/\" rel=\"bookmark\">Old data? CDC apparently misjudged California&#8217;s COVID risks<\/a><\/h3>\t\t\t\t\t\t<p>The CDC said half of Californians live in high-risk counties. But the agency apparently relied on outdated numbers of COVID infections and patients. Newer data indicates only 19 counties are in the CDC\u2019s riskiest category, where universal masking is advised.<\/p>\n\t\t\t\t<div class=\"entry-meta\">\n\t\t\t\t\t<a href=\"https:\/\/calmatters.org\/_ko\/author\/kristen-hwang\/\"><img data-recalc-dims=\"1\" alt='\uc544\ubc14\ud0c0 \uc0ac\uc9c4' src=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Kristen-Hwang.jpg?resize=48%2C48&#038;ssl=1\" srcset='https:\/\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Kristen-Hwang-96x96.jpg 2x' class='avatar avatar-48 photo' height=\"48\" width=\"48\" \/><\/a><a href=\"https:\/\/calmatters.org\/_ko\/author\/anaibarra\/\"><img data-recalc-dims=\"1\" alt='\uc544\ubc14\ud0c0 \uc0ac\uc9c4' src=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra.jpg?resize=48%2C48&#038;ssl=1\" srcset='https:\/\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra-96x96.jpg 2x' class='avatar avatar-48 photo' height=\"48\" width=\"48\" \/><\/a>\t\t\t\t\t\t<span class=\"byline\" data-no-translation=\"\">\n\t\t\t\t\t\t\t<span class=\"author-prefix\">by<\/span> <span class=\"author vcard\"><a class=\"url fn n\" href=\"https:\/\/calmatters.org\/_ko\/author\/kristen-hwang\/\">Kristen Hwang<\/a><\/span> and <span class=\"author vcard\"><a class=\"url fn n\" href=\"https:\/\/calmatters.org\/_ko\/author\/anaibarra\/\">Ana B. Ibarra<\/a><\/span>\t\t\t\t\t\t<\/span><!-- .author-name -->\n\t\t\t\t\t\t<time class=\"entry-date published updated\" datetime=\"2022-03-02T05:28:00-08:00\" data-no-translation=\"\">3\uc6d4 2, 2022<\/time>\t\t\t\t<\/div><!-- .entry-meta -->\n\t\t\t\t\t\t\t\t<\/div><!-- .entry-wrapper -->\n\t<\/article>\n\n\t\t\t\t<\/div>\n\t\t\n\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Health officials say a key difference between this upcoming winter and the last two is the wider availability of COVID antivirals like Paxlovid. But many infected people aren\u2019t aware of their availability or have difficulty accessing them. <\/p>","protected":false},"author":157,"featured_media":281448,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"_stopmodifiedupdate":false,"_modified_date":"","newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","apple_news_api_created_at":"2022-12-05T13:30:11Z","apple_news_api_id":"7af9f9be-c7f1-49d0-b552-12c3d052d9f3","apple_news_api_modified_at":"2023-05-02T20:59:10Z","apple_news_api_revision":"AAAAAAAAAAAAAAAAAAAABQ==","apple_news_api_share_url":"https:\/\/apple.news\/Aevn5vsfxSdC1UhLD0FLZ8w","apple_news_cover_media_provider":"image","apple_news_coverimage":0,"apple_news_coverimage_caption":"","apple_news_cover_video_id":0,"apple_news_cover_video_url":"","apple_news_cover_embedwebvideo_url":"","apple_news_is_hidden":"","apple_news_is_paid":"","apple_news_is_preview":"","apple_news_is_sponsored":"","apple_news_maturity_rating":"","apple_news_metadata":"\"\"","apple_news_pullquote":"","apple_news_pullquote_position":"","apple_news_slug":"","apple_news_sections":[],"apple_news_suppress_video_url":false,"apple_news_use_image_component":false,"_spanish_translation_id":0,"_is_translation":false,"_newspack_byline_active":false,"_newspack_byline":"","newspack_content_restriction_is_exempt":false,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28393,9],"tags":[60504,26758,26759,3045],"legislator":[],"bill":[],"newspack_spnsrs_tax":[],"coauthors":[25977],"class_list":["post-281800","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus","category-health","tag-california-department-of-public-health","tag-coronavirus","tag-covid-19","tag-public-health","entry"],"acf":[],"apple_news_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>COVID antivirals: Supply is increasing. Use isn\u2019t - CalMatters<\/title>\n<meta name=\"description\" content=\"There are more COVID antivirals available but many patients aren\u2019t aware the treatment is an option for them, or they have difficulty getting it.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them\" \/>\n<meta property=\"og:description\" content=\"There are more COVID antivirals available but many patients aren\u2019t aware the treatment is an option for them, or they have difficulty getting it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/\" \/>\n<meta property=\"og:site_name\" content=\"CalMatters\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/calmatters\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-05T13:30:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T20:59:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ana B. Ibarra\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@CalMatters\" \/>\n<meta name=\"twitter:site\" content=\"@CalMatters\" \/>\n<meta name=\"twitter:label1\" content=\"\uae00\uc4f4\uc774\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana B. Ibarra\" \/>\n\t<meta name=\"twitter:label2\" content=\"\uc608\uc0c1 \ub418\ub294 \ud310\ub3c5 \uc2dc\uac04\" \/>\n\t<meta name=\"twitter:data2\" content=\"7\ubd84\" \/>\n\t<meta name=\"twitter:label3\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data3\" content=\"Ana B. Ibarra\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/\"},\"author\":{\"name\":\"Ana B. Ibarra\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/#\\\/schema\\\/person\\\/e1d79334d4299e7197d8df48ca26293c\"},\"headline\":\"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them\",\"datePublished\":\"2022-12-05T13:30:00+00:00\",\"dateModified\":\"2023-05-02T20:59:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/\"},\"wordCount\":1412,\"publisher\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1\",\"keywords\":[\"California Department of Public Health\",\"Coronavirus\",\"covid-19\",\"public health\"],\"articleSection\":[\"Coronavirus\",\"Health\"],\"inLanguage\":\"ko-KR\",\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/_ko\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/\",\"url\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/\",\"name\":\"COVID antivirals: Supply is increasing. Use isn\u2019t - CalMatters\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1\",\"datePublished\":\"2022-12-05T13:30:00+00:00\",\"dateModified\":\"2023-05-02T20:59:05+00:00\",\"description\":\"There are more COVID antivirals available but many patients aren\u2019t aware the treatment is an option for them, or they have difficulty getting it.\",\"inLanguage\":\"ko-KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/health\\\/2022\\\/12\\\/covid-antivirals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1\",\"width\":2000,\"height\":1333,\"caption\":\"A box of the COVID-19 treatment pill Paxlovid on Feb. 8, 2022. Photo by Jennifer Lorenzini, Reuters\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/#website\",\"url\":\"https:\\\/\\\/calmatters.org\\\/\",\"name\":\"CalMatters\",\"description\":\"California, explained\",\"publisher\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/calmatters.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ko-KR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/#organization\",\"name\":\"CalMatters\",\"url\":\"https:\\\/\\\/calmatters.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/calmatters-logo_2x.png?fit=488%2C82&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/calmatters-logo_2x.png?fit=488%2C82&ssl=1\",\"width\":488,\"height\":82,\"caption\":\"CalMatters\"},\"image\":{\"@id\":\"https:\\\/\\\/calmatters.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/calmatters\\\/\",\"https:\\\/\\\/x.com\\\/CalMatters\",\"https:\\\/\\\/www.instagram.com\\\/calmatters\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/calmatters\\\/\",\"https:\\\/\\\/www.youtube.com\\\/calmatters\"],\"foundingDate\":\"2015-07-18\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"},\"publishingPrinciples\":\"https:\\\/\\\/calmatters.org\\\/about\\\/policies-and-standards\\\/\",\"ownershipFundingInfo\":\"https:\\\/\\\/calmatters.org\\\/about\\\/funding\\\/\",\"ethicsPolicy\":\"https:\\\/\\\/calmatters.org\\\/about\\\/policies-and-standards\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/#\\\/schema\\\/person\\\/e1d79334d4299e7197d8df48ca26293c\",\"name\":\"Ana B. Ibarra\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ko-KR\",\"@id\":\"https:\\\/\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-Ana-B.-Ibarra-96x96.jpg838b146772c4c4ca7c96f4ac54653e86\",\"url\":\"https:\\\/\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-Ana-B.-Ibarra-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/calmatters.org\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-Ana-B.-Ibarra-96x96.jpg\",\"caption\":\"Ana B. Ibarra\"},\"description\":\"Ana B. Ibarra covers health care for CalMatters. Her reporting largely focuses on issues around access to care and affordability. She joined CalMatters in 2020 after four years at Kaiser Health News. She started her reporting career at McClatchy\u2019s Merced Sun-Star. Her work has also appeared in The Washington Post, the Los Angeles Times, USA Today and other state and national news outlets.\",\"knowsLanguage\":[\"English\",\"Spanish\"],\"url\":\"https:\\\/\\\/calmatters.org\\\/_ko\\\/author\\\/anaibarra\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"COVID antivirals: Supply is increasing. Use isn\u2019t - CalMatters","description":"There are more COVID antivirals available but many patients aren\u2019t aware the treatment is an option for them, or they have difficulty getting it.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/","og_locale":"ko_KR","og_type":"article","og_title":"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them","og_description":"There are more COVID antivirals available but many patients aren\u2019t aware the treatment is an option for them, or they have difficulty getting it.","og_url":"https:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/","og_site_name":"CalMatters","article_publisher":"https:\/\/www.facebook.com\/calmatters\/","article_published_time":"2022-12-05T13:30:00+00:00","article_modified_time":"2023-05-02T20:59:05+00:00","og_image":[{"width":2000,"height":1333,"url":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1","type":"image\/jpeg"}],"author":"Ana B. Ibarra","twitter_card":"summary_large_image","twitter_creator":"@CalMatters","twitter_site":"@CalMatters","twitter_misc":{"\uae00\uc4f4\uc774":"Ana B. Ibarra","\uc608\uc0c1 \ub418\ub294 \ud310\ub3c5 \uc2dc\uac04":"7\ubd84","Written by":"Ana B. Ibarra"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/#article","isPartOf":{"@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/"},"author":{"name":"Ana B. Ibarra","@id":"https:\/\/calmatters.org\/#\/schema\/person\/e1d79334d4299e7197d8df48ca26293c"},"headline":"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them","datePublished":"2022-12-05T13:30:00+00:00","dateModified":"2023-05-02T20:59:05+00:00","mainEntityOfPage":{"@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/"},"wordCount":1412,"publisher":{"@id":"https:\/\/calmatters.org\/#organization"},"image":{"@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1","keywords":["California Department of Public Health","Coronavirus","covid-19","public health"],"articleSection":["Coronavirus","Health"],"inLanguage":"ko-KR","copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/calmatters.org\/_ko\/#organization"}},{"@type":"WebPage","@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/","url":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/","name":"COVID antivirals: Supply is increasing. Use isn\u2019t - CalMatters","isPartOf":{"@id":"https:\/\/calmatters.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/#primaryimage"},"image":{"@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1","datePublished":"2022-12-05T13:30:00+00:00","dateModified":"2023-05-02T20:59:05+00:00","description":"There are more COVID antivirals available but many patients aren\u2019t aware the treatment is an option for them, or they have difficulty getting it.","inLanguage":"ko-KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/"]}]},{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/calmatters.org\/health\/2022\/12\/covid-antivirals\/#primaryimage","url":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1","contentUrl":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1","width":2000,"height":1333,"caption":"A box of the COVID-19 treatment pill Paxlovid on Feb. 8, 2022. Photo by Jennifer Lorenzini, Reuters"},{"@type":"WebSite","@id":"https:\/\/calmatters.org\/#website","url":"https:\/\/calmatters.org\/","name":"\uce7c\ub9e4\ud130\uc2a4","description":"\uce98\ub9ac\ud3ec\ub2c8\uc544\uc5d0 \ub300\ud55c \uc124\uba85","publisher":{"@id":"https:\/\/calmatters.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/calmatters.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ko-KR"},{"@type":"Organization","@id":"https:\/\/calmatters.org\/#organization","name":"\uce7c\ub9e4\ud130\uc2a4","url":"https:\/\/calmatters.org\/","logo":{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/calmatters.org\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2019\/07\/calmatters-logo_2x.png?fit=488%2C82&ssl=1","contentUrl":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2019\/07\/calmatters-logo_2x.png?fit=488%2C82&ssl=1","width":488,"height":82,"caption":"CalMatters"},"image":{"@id":"https:\/\/calmatters.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/calmatters\/","https:\/\/x.com\/CalMatters","https:\/\/www.instagram.com\/calmatters\/","https:\/\/www.linkedin.com\/company\/calmatters\/","https:\/\/www.youtube.com\/calmatters"],"foundingDate":"2015-07-18","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"},"publishingPrinciples":"https:\/\/calmatters.org\/about\/policies-and-standards\/","ownershipFundingInfo":"https:\/\/calmatters.org\/about\/funding\/","ethicsPolicy":"https:\/\/calmatters.org\/about\/policies-and-standards\/"},{"@type":"Person","@id":"https:\/\/calmatters.org\/#\/schema\/person\/e1d79334d4299e7197d8df48ca26293c","name":"\uc544\ub098 B. \uc774\ubc14\ub77c","image":{"@type":"ImageObject","inLanguage":"ko-KR","@id":"https:\/\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra-96x96.jpg838b146772c4c4ca7c96f4ac54653e86","url":"https:\/\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra-96x96.jpg","contentUrl":"https:\/\/calmatters.org\/wp-content\/uploads\/2023\/12\/cropped-Ana-B.-Ibarra-96x96.jpg","caption":"Ana B. Ibarra"},"description":"Ana B. Ibarra covers health care for CalMatters. Her reporting largely focuses on issues around access to care and affordability. She joined CalMatters in 2020 after four years at Kaiser Health News. She started her reporting career at McClatchy\u2019s Merced Sun-Star. Her work has also appeared in The Washington Post, the Los Angeles Times, USA Today and other state and national news outlets.","knowsLanguage":["English","Spanish"],"url":"https:\/\/calmatters.org\/_ko\/author\/anaibarra\/"}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them","url":"http:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/","mainEntityOfPage":{"@type":"WebPage","@id":"http:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/"},"thumbnailUrl":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?resize=60%2C60&ssl=1","image":{"@type":"ImageObject","url":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1"},"articleSection":"Coronavirus","author":[{"@type":"Person","name":"\uc544\ub098 B. \uc774\ubc14\ub77c"}],"creator":["Ana B. Ibarra"],"publisher":{"@type":"Organization","name":"\uce7c\ub9e4\ud130\uc2a4","logo":"https:\/\/calmatters.org\/wp-content\/uploads\/2019\/07\/calmatters-logo_2x.png"},"keywords":["california department of public health","coronavirus","covid-19","public health"],"dateCreated":"2022-12-05T13:30:00Z","datePublished":"2022-12-05T13:30:00Z","dateModified":"2023-05-02T20:59:05Z"},"rendered":"<meta name=\"parsely-title\" content=\"The supply of COVID antivirals is increasing, but many patients aren\u2019t using them\" \/>\n<meta name=\"parsely-link\" content=\"http:\/\/calmatters.org\/_ko\/health\/2022\/12\/covid-antivirals\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?resize=60%2C60&amp;ssl=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2022-12-05T13:30:00Z\" \/>\n<meta name=\"parsely-section\" content=\"Coronavirus\" \/>\n<meta name=\"parsely-tags\" content=\"california department of public health,coronavirus,covid-19,public health\" \/>\n<meta name=\"parsely-author\" content=\"Ana B. Ibarra\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/calmatters.org\/p.js"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/calmatters.org\/wp-content\/uploads\/2022\/06\/113022-PAXLOVID-REUTERS-JL-CM.jpg?fit=2000%2C1333&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/posts\/281800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/users\/157"}],"replies":[{"embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/comments?post=281800"}],"version-history":[{"count":17,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/posts\/281800\/revisions"}],"predecessor-version":[{"id":299328,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/posts\/281800\/revisions\/299328"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/media\/281448"}],"wp:attachment":[{"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/media?parent=281800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/categories?post=281800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/tags?post=281800"},{"taxonomy":"legislator","embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/legislator?post=281800"},{"taxonomy":"bill","embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/bill?post=281800"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=281800"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/calmatters.org\/_ko\/wp-json\/wp\/v2\/coauthors?post=281800"}],"curies":[{"name":"\uc6cc\ub4dc\ud504\ub808\uc2a4","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}